Gold nanorod--siRNA induces efficient in vivo gene silencing in the rat hippocampus.
暂无分享,去创建一个
Hong Ding | Rui Hu | Ken-Tye Yong | Arin Bhattacharjee | Earl J. Bergey | Supriya D. Mahajan | Adela C. Bonoiu | Rajiv Kumar | R. Kumar | A. Bhattacharjee | Hong Ding | K. Yong | Rui Hu | S. Mahajan | P. Prasad | E. Bergey | A. Bonoiu | Paras N. Prasad | Kelly E. Picchione | Tracey A. Ignatowski | T. A. Ignatowski
[1] Paras N. Prasad,et al. Introduction to Biophotonics , 2003 .
[2] Ying Liu,et al. Surface chemistry and aspect ratio mediated cellular uptake of Au nanorods. , 2010, Biomaterials.
[3] Adela C. Bonoiu,et al. Gold nanorod delivery of an ssRNA immune activator inhibits pandemic H1N1 influenza viral replication , 2010, Proceedings of the National Academy of Sciences.
[4] Yu-cheng Tseng,et al. Biodegradable calcium phosphate nanoparticle with lipid coating for systemic siRNA delivery. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[5] Mark E. Davis,et al. Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles , 2010, Nature.
[6] M. El-Sayed,et al. Nuclear targeting of gold nanoparticles in cancer cells induces DNA damage, causing cytokinesis arrest and apoptosis. , 2010, Journal of the American Chemical Society.
[7] Leaf Huang,et al. Nanoparticles evading the reticuloendothelial system: role of the supported bilayer. , 2009, Biochimica et biophysica acta.
[8] Hong Ding,et al. Biocompatible near-infrared quantum dots as ultrasensitive probes for long-term in vivo imaging applications. , 2009, Small.
[9] A. Bhattacharjee,et al. cAMP-dependent kinase does not modulate the Slack sodium-activated potassium channel , 2009, Neuropharmacology.
[10] P. Sharp,et al. Functional Delivery of siRNA in Mice Using Dendriworms , 2009, ACS nano.
[11] E. Marbán,et al. Targeted knock-down of neuronal nitric oxide synthase expression in basal forebrain with RNA interference , 2009, Journal of Neuroscience Methods.
[12] Adela C. Bonoiu,et al. Nanotechnology approach for drug addiction therapy: Gene silencing using delivery of gold nanorod-siRNA nanoplex in dopaminergic neurons , 2009, Proceedings of the National Academy of Sciences.
[13] Mark E. Davis. The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic. , 2009, Molecular pharmaceutics.
[14] D. Thakker,et al. Intracerebroventricular amyloid-β antibodies reduce cerebral amyloid angiopathy and associated micro-hemorrhages in aged Tg2576 mice , 2009, Proceedings of the National Academy of Sciences.
[15] P. Prasad,et al. Preparation of Gold Nanoparticles and their Applications in Anisotropic Nanoparticle Synthesis and Bioimaging , 2009 .
[16] Hong Ding,et al. Metallic Nanostructures as Localized Plasmon Resonance Enhanced Scattering Probes for Multiplex Dark Field Targeted Imaging of Cancer Cells. , 2009, The journal of physical chemistry. C, Nanomaterials and interfaces.
[17] Vincent M Rotello,et al. Gold nanoparticles in delivery applications. , 2008, Advanced drug delivery reviews.
[18] M. Stachowiak,et al. Nonviral gene transfection nanoparticles: function and applications in the brain. , 2008, Nanomedicine : nanotechnology, biology, and medicine.
[19] Rebecca Richards-Kortum,et al. Aptamer-Targeted Gold Nanoparticles As Molecular-Specific Contrast Agents for Reflectance Imaging , 2008, Bioconjugate chemistry.
[20] M. Swihart,et al. Templated Synthesis of Gold Nanorods (NRs): The Effects of Cosurfactants and Electrolytes on the Shape and Optical Properties , 2008 .
[21] Arezou A Ghazani,et al. Assessing the effect of surface chemistry on gold nanorod uptake, toxicity, and gene expression in mammalian cells. , 2008, Small.
[22] L. Sui,et al. Down-regulation of β1-adrenoceptors gene expression by short interfering RNA impairs the memory retrieval in the basolateral amygdala of rats , 2007, Neuroscience Letters.
[23] P. Jain,et al. Gold nanoparticles: interesting optical properties and recent applications in cancer diagnostics and therapy. , 2007, Nanomedicine.
[24] I. Roy,et al. ORMOSIL nanoparticles as a non-viral gene delivery vector for modeling polyglutamine induced brain pathology , 2007, Journal of Neuroscience Methods.
[25] Hong Ding,et al. Gold Nanorods Coated with Multilayer Polyelectrolyte as Contrast Agents for Multimodal Imaging , 2007 .
[26] Mark E. Davis,et al. Effect of siRNA nuclease stability on the in vitro and in vivo kinetics of siRNA‐mediated gene silencing , 2007, Biotechnology and bioengineering.
[27] Joseph Irudayaraj,et al. Identity profiling of cell surface markers by multiplex gold nanorod probes. , 2007, Nano letters.
[28] W. Pardridge. shRNA and siRNA delivery to the brain. , 2007, Advanced drug delivery reviews.
[29] Daniel Hoyer,et al. RNA interference for studying the molecular basis of neuropsychiatric disorders. , 2007, Current opinion in drug discovery & development.
[30] Shan Jiang,et al. Quantum-dot based nanoparticles for targeted silencing of HER2/neu gene via RNA interference. , 2007, Biomaterials.
[31] L. Chau,et al. Sensing capability of the localized surface plasmon resonance of gold nanorods. , 2007, Biosensors & bioelectronics.
[32] J. Krueger,et al. TNFalpha siRNA reduces brain TNF and EEG delta wave activity in rats. , 2007, Brain Research.
[33] R. Juliano,et al. Tat-Conjugated PAMAM Dendrimers as Delivery Agents for Antisense and siRNA Oligonucleotides , 2005, Pharmaceutical Research.
[34] John F. Cryan,et al. Model organisms: The ascent of mouse: advances in modelling human depression and anxiety , 2005, Nature Reviews Drug Discovery.
[35] E. Stachowiak,et al. Organically modified silica nanoparticles: a nonviral vector for in vivo gene delivery and expression in the brain. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[36] P. Whittaker,et al. RNA interference: From gene silencing to gene-specific therapeutics , 2005, Pharmacology & Therapeutics.
[37] C. Murphy,et al. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. , 2005, Small.
[38] M. Ferrari. Cancer nanotechnology: opportunities and challenges , 2005, Nature Reviews Cancer.
[39] George M Whitesides,et al. Nanoscience, nanotechnology, and chemistry. , 2005, Small.
[40] F. Natt,et al. Neurochemical and behavioral consequences of widespread gene knockdown in the adult mouse brain by using nonviral RNA interference. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[41] W. Siegert,et al. Guideline to reference gene selection for quantitative real-time PCR. , 2004, Biochemical and biophysical research communications.
[42] S A Bustin,et al. Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems. , 2002, Journal of molecular endocrinology.
[43] C. R Bjarkam,et al. New strategies for embedding, orientation and sectioning of small brain specimens enable direct correlation to MR-images, brain atlases, or use of unbiased stereology , 2001, Journal of Neuroscience Methods.
[44] R. Spengler,et al. Neuronal-associated tumor necrosis factor (TNFα): its role in noradrenergic functioning and modification of its expression following antidepressant drug administration , 1997, Journal of Neuroimmunology.
[45] V. Debabov. Biotechnology and Chemistry , 1991 .
[46] P. Chomczyński,et al. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.
[47] G. Paxinos,et al. The Rat Brain in Stereotaxic Coordinates , 1983 .